Ponatinib Evaluation And safety in Real Life CML patients failing ≥2 tyrosine kinase inhibitors: The PEARL observational study
Heiblig, Maël, Rea, Delphine, Chrétien, Marie-Lorraine, Charbonnier, Aude, Rousselot, Philippe, Coiteux, Valérie, Escoffre-Barbe, Martine, Dubruille, Viviane, Huguet, Françoise, Cayssials, Emilie, HerLanguage:
english
Journal:
Experimental Hematology
DOI:
10.1016/j.exphem.2018.08.006
Date:
September, 2018
File:
PDF, 881 KB
english, 2018